Table 1. Clinical characteristics of the... | American Society of Hematology

Table 1.

Clinical characteristics of the VEBIOS discovery study

	89 Cases		88 Controls
Variables	N	Freq.	N	Freq.
Localization of the thrombosis
DVT, lower limbs	47	0.53
Proximal	36	0.77
PE	45	0.51
Gender and biometry
Gender, women	35	0.39	35	0.39
Age, y (mean ± SD and range)	51.1 ± 10.8	(20-70)	51.6 ± 10.8	(21-70)
BMI, kg/m² (mean ± SD and range)	26.7 ± 4.6	(17-46)	25.6 ± 4	(19-38)
Obese, BMI ≥ 30 kg/m²	20	0.22	16	0.19
Cardiovascular risk factors
Hypertension*	19	0.21	10	0.11
Hyperlipidemia*	5	0.06	5	0.06
Diabetes mellitus*	2	0.02	5	0.06
Current smoking†	15	0.17	7	0.08
Family history
VTE, first-degree relative <60 y old	15	0.17	1	0.01
Provoked risk factors‡	39	0.44	17	0.19
Trauma	22	0.22	7	0.08
Cast, orthosis, etc	15	0.17	1	0.01
Surgery	16	0.18	2	0.02
Pregnancy, postpartum 3 mo	0	0	0	0
Contraceptives§	11	0.31	9	0.26
Menopausal replacement therapy#	5	0.14	1	0.03

	89 Cases		88 Controls
Variables	N	Freq.	N	Freq.
Localization of the thrombosis
DVT, lower limbs	47	0.53
Proximal	36	0.77
PE	45	0.51
Gender and biometry
Gender, women	35	0.39	35	0.39
Age, y (mean ± SD and range)	51.1 ± 10.8	(20-70)	51.6 ± 10.8	(21-70)
BMI, kg/m² (mean ± SD and range)	26.7 ± 4.6	(17-46)	25.6 ± 4	(19-38)
Obese, BMI ≥ 30 kg/m²	20	0.22	16	0.19
Cardiovascular risk factors
Hypertension*	19	0.21	10	0.11
Hyperlipidemia*	5	0.06	5	0.06
Diabetes mellitus*	2	0.02	5	0.06
Current smoking†	15	0.17	7	0.08
Family history
VTE, first-degree relative <60 y old	15	0.17	1	0.01
Provoked risk factors‡	39	0.44	17	0.19
Trauma	22	0.22	7	0.08
Cast, orthosis, etc	15	0.17	1	0.01
Surgery	16	0.18	2	0.02
Pregnancy, postpartum 3 mo	0	0	0	0
Contraceptives§	11	0.31	9	0.26
Menopausal replacement therapy#	5	0.14	1	0.03

freq., frequency; N, numbers; SD, standard deviation.

Medical treatment.

Daily within the last year.

Within 3 mo from diagnose or index date.

Estrogen containing (oral, patch, vaginal devices).

Estrogen containing (oral only).